Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study
Academic Article
Publication Date:
2016
Short description:
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study / Teerlink, John R; Felker, G Michael; Mcmurray, John J V; Ponikowski, Piotr; Metra, Marco; Filippatos, Gerasimos S; Ezekowitz, Justin A; Dickstein, Kenneth; Cleland, John G F; Kim, Jae B; Lei, Lei; Knusel, Beat; Wolff, Andrew A; Malik, Fady I; Wasserman, Scott M. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 1558-3597. - 67:12(2016), pp. 1444-1455. [10.1016/j.jacc.2016.01.031]
abstract:
Omecamtiv mecarbil (OM) is a selective cardiac myosin activator that increases myocardial function in healthy volunteers and in patients with chronic heart failure.
Iris type:
1.1 Articolo in rivista
Keywords:
arrhythmia; cardiac myosin activator; dyspnea; inotrope
List of contributors:
Teerlink, John R; Felker, G Michael; Mcmurray, John J V; Ponikowski, Piotr; Metra, Marco; Filippatos, Gerasimos S; Ezekowitz, Justin A; Dickstein, Kenneth; Cleland, John G F; Kim, Jae B; Lei, Lei; Knusel, Beat; Wolff, Andrew A; Malik, Fady I; Wasserman, Scott M
Published in: